Clinical Performance Partners Launches New Web Site
Clinical Performance Partners, Inc. (CPP) announces the launch of their website (www.clinicalperformancepartners.com).
Contact: Beth Harper FOR IMMEDIATE RELEASE
Phone: 817-946-4892
Email: bharper@clinicalperformancepartners.com
CLINICAL PERFORMANCE PARTNERS LAUNCHES NEW WEBSITE
KELLER, TX June 19, 2008 – Clinical Performance Partners, Inc. (CPP) announces the launch of their website (www.clinicalperformancepartners.com).
“In addition to establishing a web presence for the company, the goal of the website is to serve as a valuable resource to the industry for all things related to patient recruitment / retention and site relationship management” says Beth Harper, President of Clinical Performance Partners, Inc.
The website features a listing of patient recruitment service providers with links to their websites. In addition, viewers can search for articles related to patient recruitment and site relationship management, as well as download sample tools and templates developed by CPP, Inc.
“As a long-time champion and advocate for educating the industry on the process and practice of patient recruitment, I am delighted to share my interest, experience and resources as we all strive to overcome the chronic challenges associated with patient recruitment” says Harper.
“Predicting, managing, supporting and enhancing site performance in clinical trials is not only our mission by my personal passion” notes Harper who celebrates some 25 years of “in the trenches” healthcare and clinical research experience this year.
About Clinical Performance Partners - CPP is a consulting firm dedicated to designing and implementing innovative and practical solutions for improving site performance and accelerating clinical trials results for the Life Sciences Industry. www.clinicalperformancepartners.com
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
